Vanessa Bonomi

Chief Quality & Regulatory Officer at GreenBone Ortho S.p.A.

Vanessa Bonomi has over 20 years of work experience in the regulatory affairs and quality management field. Vanessa is currently serving as the Chief Quality & Regulatory Officer at GreenBone Ortho S.p.A., a position they have held since January 2023. Prior to this, they worked at Copan Group as a Senior Manager Regulatory Affairs from March 2019 to January 2022. Vanessa also held the role of Regulatory Affairs Manager at Copan Group from May 2013 to March 2019. Before joining Copan Group, Vanessa worked as a Clinical Research Associate at MeDePha-Medicinal Development Pharma srl from December 2012 to May 2013. Additionally, they held the position of Regulatory Market Specialist at Orthofix from May 2010 to November 2012. Earlier in their career, they worked as a Regulatory Affairs professional at IZO spa from August 2006 to May 2010 and as a Researcher at Istituto di Medicina Molecolare "A.Nocivelli"-Spedali Civili di Brescia from September 2003 to July 2006.

Vanessa Bonomi's education history begins in 1998 when they enrolled at Università degli Studi di Milano. Vanessa pursued a Laurea in scienze biologiche, specializing in Biological and Biomedical Sciences, and completed their degree in 2004.

After a gap of several years, Vanessa resumed their education in 2012. Vanessa attended Università degli Studi di Milano-Bicocca and pursued a Master's degree related to Ricerca e sviluppo preclinico e clinico dei farmaci, which translates to Preclinical and Clinical Drug Research and Development. Vanessa completed this program in 2013.

Based on the provided information, it can be concluded that Vanessa Bonomi has obtained a Bachelor's degree in Biological and Biomedical Sciences and a Master's degree in Drug Research and Development, with a focus on preclinical and clinical aspects.

Links

Previous companies

Orthofix logo

Timeline

  • Chief Quality & Regulatory Officer

    January, 2023 - present

  • Senior Regulatory & Quality Manager

    February, 2022